Holen Sie sich die Stockscreener-App
11.28
6.21%
0.66
Vorhandelsmarkt:
11.27
-0.010
-0.09%
Schlusskurs vom Vortag:
$10.62
Offen:
$10.62
24-Stunden-Volumen:
272.77K
Relative Volume:
0.70
Marktkapitalisierung:
$153.65M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-97.17M
KGV:
-1.5111
EPS:
-7.465
Netto-Cashflow:
$-85.97M
1W Leistung:
+4.93%
1M Leistung:
-2.76%
6M Leistung:
+56.04%
1J Leistung:
+0.71%
1-Tages-Spanne:
$10.12
$11.29
1-Wochen-Bereich:
$9.0501
$11.29
52-Wochen-Spanne:
$5.062
$15.10
Immunic Inc Stock (IMUX) Company Profile
Firmenname
Immunic Inc
Sektor
Branche
Telefon
(332) 255-9818
Adresse
1200 AVENUE OF THE AMERICAS, NEW YORK
Compare IMUX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMUX
Immunic Inc
|
11.28 | 153.65M | 0 | -97.17M | -85.97M | -7.465 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-17 | Eingeleitet | Stifel | Buy |
| 2026-04-15 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2026-03-24 | Eingeleitet | Guggenheim | Buy |
| 2025-11-07 | Eingeleitet | Roth Capital | Buy |
| 2025-09-29 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-25 | Eingeleitet | William Blair | Outperform |
| 2024-11-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-08-27 | Eingeleitet | B. Riley Securities | Buy |
| 2022-10-21 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-04-15 | Eingeleitet | Aegis Capital | Buy |
| 2021-03-24 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-10-02 | Eingeleitet | SVB Leerink | Outperform |
| 2020-08-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-07 | Fortgesetzt | ROTH Capital | Buy |
| 2020-07-20 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-06-05 | Eingeleitet | Wedbush | Outperform |
| 2020-05-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-03-25 | Eingeleitet | ROTH Capital | Buy |
| 2019-07-11 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Immunic Inc Aktie (IMUX) Neueste Nachrichten
LifeSci Capital Initiates Immunic(IMUX.US) With Buy Rating, Announces Target Price $56 - Moomoo
[EFFECT] IMMUNIC, INC. SEC Filing - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Immunic to Participate in Investor and Medical Conferences in May - Sahm
Who's Buying or Selling Immunic Inc (HAM:10V) Stock Today? - GuruFocus
Immunic Inc (HAM:10V) Valuation - GuruFocus
Immunic Inc (HAM:10V) Dividend - GuruFocus
Immunic Inc (HAM:10V) Stock Price & 30 Year Financial Data - GuruFocus
Immunic Inc (HAM:10V) Competitors 2026 - GuruFocus
Immunic Inc (HAM:10V)Valuation Measures & Financial Statistics - GuruFocus
Immunic Inc Stock Baskets | HAM:10V - GuruFocus
Immunic Inc (HAM:10V) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Immunic Inc Stock Operating Data - GuruFocus
Immunic Inc (HAM:10V) Stock News, Headlines & Updates - GuruFocus
Immunic Inc (HAM:10V) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Immunic Inc (HAM:10V) Stock Earnings Transcripts - GuruFocus
Immunic (NASDAQ: IMUX) registers 45.8M shares after 1-for-10 reverse split - Stock Titan
Q3 2024 Immunic Inc Earnings Call Transcript - GuruFocus
Immunic (IMUX) price target increased by 920.41% to 54.64 - MSN
Immunic Inc (STU:10V) Stock Price & 30 Year Financial Data - GuruFocus
Immunic Inc (STU:10V) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Immunic Inc (STU:10V) Stock Earnings Transcripts - GuruFocus
H.C. Wainwright Maintains Immunic(IMUX.US) With Buy Rating, Cuts Target Price to $22 - Moomoo
IMUX Maintained by HC Wainwright & Co. -- Price Target Raised to $5.00 - GuruFocus
H.C. Wainwright raises Immunic stock price target to $22 on MS drug prospects By Investing.com - Investing.com India
H.C. Wainwright raises Immunic stock price target to $22 on MS drug prospects - Investing.com UK
Immunic (IMUX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Immunic Is Maintained at Buy by HC Wainwright & Co. - Moomoo
Immunic to present MS data, meet investors at May conferences - Proactive financial news
IMUX Forecast, Price Target & Analyst Ratings | IMMUNIC INC (NASDAQ:IMUX) - ChartMill
Immunic, Inc. Common Stock (IMUX) Stock Price Today & Analysis - Gotrade
Debt to equity ratio of Immunic, Inc. – MUN:10V - TradingView
Total liabilities & shareholders' equities of Immunic, Inc. – MUN:10V - TradingView
Current ratio of Immunic, Inc. – MUN:10V - TradingView
Diluted earnings per share (diluted EPS) of Immunic, Inc. – MUN:10V - TradingView
Debt to equity ratio of Immunic, Inc. – LSX:A428WY - TradingView
Pretax income of Immunic, Inc. – MUN:10V - TradingView
Net income of Immunic, Inc. – MUN:10V - TradingView
Debt to equity ratio of Immunic, Inc. – LS:A428WY - TradingView
Total debt per share of Immunic, Inc. – MUN:10V - TradingView
After tax other income/expense of Immunic, Inc. – LS:A428WY - TradingView
Immunic (IMUX) awards CMO 300,000 stock options at $8.80 - Stock Titan
Immunic (IMUX) Chief Medical Officer Michael Panzara files initial Form 3 insider report - Stock Titan
Enterprise value to EBITDA ratio of Immunic, Inc. – TRADEGATE:10V - TradingView
Long term debt to total assets ratio of Immunic, Inc. – TRADEGATE:10V - TradingView
Immunic, Inc. Cash Flow – FWB:10V - TradingView
Asset turnover of Immunic, Inc. – FWB:10V - TradingView
Total liabilities & shareholders' equities of Immunic, Inc. – FWB:10V - TradingView
EBIT per share of Immunic, Inc. – GETTEX:10V - TradingView
Taxes of Immunic, Inc. – GETTEX:10V - TradingView
Current ratio of Immunic, Inc. – GETTEX:10V - TradingView
Finanzdaten der Immunic Inc-Aktie (IMUX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Immunic Inc-Aktie (IMUX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Tardio Jason | President and COO |
Jun 05 '25 |
Buy |
0.79 |
12,512 |
9,884 |
12,512 |
| Vitt Daniel | CEO and Director |
Jun 04 '25 |
Buy |
0.77 |
15,000 |
11,550 |
29,000 |
| Neermann Joerg | Director |
Jun 04 '25 |
Buy |
0.77 |
70,000 |
53,900 |
170,000 |
| Neermann Joerg | Director |
Jun 05 '25 |
Buy |
0.76 |
30,000 |
22,800 |
200,000 |
| Whaley Glenn | Chief Financial Officer |
Jun 03 '25 |
Buy |
0.71 |
45,000 |
32,076 |
95,510 |
| Rudick Richard Alan | Director |
Jun 03 '25 |
Buy |
0.70 |
143,075 |
100,024 |
230,375 |
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):